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Abstract
Introduction: The raw goat milk is considered as a good source of 
novel bacteriocinogenic lactic acid bacteria (LAB) strains.
Method: The bacteriocin, which named enterocin CMUL20-2 was 
secreted by Enterococcus faecium CMUL20-2. This bacterial strain was 
originally isolated from raw goat’s milk, was extracted by using a 
modified adsorption-desorption method and purified via RP-HPLC. 
antimicrobial activity was tested against several pathogenic and spoi-
lage microbes. 
Results: The enterocin CMUL20-2 showed a strong adsorption on 
cell wall of producer strain even in acidic environment which facili-
tate its extraction in only two simple steps. The recovered purified 
enterocin has decreased procedure time and diminished the number 
of undesirable molecules present in Rogosa and Sharpe (MRS) broth. 
The recovered enterocin showed antimicrobial activity against several 
foodborne pathogenic and spoilage microbes.
Conclusion: The recovered enterocin was able to tolerate a variety 
of food chain conditions such as high temperature, pH and storage 
stability, and it can be a good candidate to protect food from spoilage 
microbes. 
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Introduction
Lactic acid bacteria (LAB) are generally recognized 
as safe (GRAS) and widely used as starter cultures 
for dairy, meat, and vegetable fermentations [1]. 
When LAB present in human or animal ecosystems, 
they play an important role in the prevention and 
treatment of bacterial and viral diseases by different 
mechanisms [2, 3]. In food sector, one of the most 
important contributions of these microorganisms 
is the extended of the shelf life of the fermented 
products. Also, they play an important role in food 
preservation due to the ability to produce several 
antimicrobial substances, including organic acids, 
hydrogen peroxide, bacteriocins, and bacteriocin-
like substances [4, 5]. Many biological hazards are 
present in dairy product food chain, these “criti-
cal points" usually controlled by pasteurization and 
chemical preservatives. Some dairy products based 
on unpasteurized milk are considered as a high risk 
products as regard as to food borne intoxication 
such as Lebanese traditional raw cheese. Listeria 
monocytogenes (L. monocytogenes), the most 
common pathogen transmitted in food, particularly 
in dairy products, can cause serious diseases such 
as enteritis, meningitis and abortion[6]cell wall-asso-
ciated internalins and one small, secreted internalin 
(InlC. The mortality rate caused by listeriosis is be-
tween 15 and 30% [7]. This pathogenic bacterium 
can be present in all dairy products especially in the 
unpasteurized one.
The raw goat milk microbiota is considered a 
good source of novel bacteriocinogenic LAB strains 
that can be exploited as an alternative for use as 
biopreservative in foods as observed in previous 
studies [8-10]. 
The aim of the present study is to characterize 
and purify the first Lebanese antimicrobial pepti-
de secreted by E. faecium CMUL20-2 isolated from 
Lebanese goat's raw milk, and to usea modified 
adsorption-desorption method which can facilitate 
the purification of potential enterocin.
Materials and Methods
LAB isolation from goat’s milk and 
assessment of their anti-listerial activity 
A total of twenty-four samples of goat’s milk were 
collected from individual households in rural areas 
of different regions in North Lebanon. Samples were 
collected aseptically in sterile bottles (100 ml), kept 
in an ice-box container (4°C) and transported to the 
laboratory for microbiological analyses. The samples 
were serial diluted, plated and streaked into DeMan, 
Rogosa and Sharpe (MRS) agar (Bio-Rad, Germany). 
150 μl of each LAB working culture were added 
to 15 ml of MRS broth and incubated at 37 °C for 
24 h. The culture broth was centrifuged at 15364 
× g for 15 minutes at 4 °C. The supernatant was 
adjusted to pH 6.0 with 2 M NaOH (Sigma-Aldrich, 
Germany) and sterilized using 0.22μm syringe filter, 
the cell-free supernatant was used as crude bacte-
riocin [11]. The assessment of anti-listerial activity 
of crude supernatant was carried out using Agar 
Well Diffusion method by using L. monocytogenes 
ATCC® 19115™ as indicator strain as described by 
[12]. To determine the nature of the antimicrobial 
compound, the crude supernatant was treated by 
proteinase K, lipase and amylase (Sigma-Aldrich, 
Germany) as describe previously by [13]. 
Strain identification
A bacterial Strain CMUL20-2 which exhibits the lar-
gest inhibition zone against L. monocytogenes was 
selected for further studies. This strain was identi-
fied accordingto the physiological and biochemical 
characteristics [14]. The identification was confirmed 
by using the pyrosequencing of V1 and V3 of 16S 
rDNA as previously described [15]. 
Extraction of enterocin CMUL20-2
Adsorption-desorption of enterocin CMUL20-2
According to Yang et al., 1992, enterocin CMUL20-
2 have been extracted by adsorption-desorption 
method [16]. 
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Stress condition as a new strategy of adsorp-
tion-desorption method
After 24 hrs of E. faecium CMUL20-2 culture, the 
pH of MRS broth was 6.0. A centrifugation of 
CMUL20-2 broth was performed directly at 15364 
× g. The pellet was inoculated in sterile PBS (pH= 
7.0) without any nutriments, for 15 min and 18 
hrs followed by a centrifugation step (15364 × 
g for 15 minutes at 4 °C) and the supernatants 
were tested.
Total purification and determination of the 
molecular weight of enterocin CMUL20-2 by 
using LC-ESI-MS/MS
The purification of enterocin CMUL20-2 was per-
formed by using RP-HPLC (Agilent/Bruker, Ger-
many) using C18 column (Supelco-58419, Sigma-
Aldrich, Germany). The direct supernatant of “PBS-
CMUL20-2 strain” – obtained from adsorption-
desorption section- was introduced into RP-HPLC 
which achieves few different fractions. Each frac-
tion was collected and tested for antilisterial acti-
vity. In order to determine the molecular weight of 
enterocin CMUL20-2, Mass spectrometry was per-
formed by using LC-ESI-MS/MS techniques (Bruker, 
Germany).
Characterization of enterocin CMUL20-2
Enterocin CMUL20-2 stability at different tem-
perature, pH and during storage
The influence of temperature on purified entero-
cin CMUL20-2 stability was determined at 37, 50, 
75 and 100 °C by using temperature-controlled 
water bath for 4, 15, 30, 60, 90 and 120 min. In 
addition, the enterocin was assessed under auto-
claving condition (121 °C, 1 atmosphere, 30 min) 
[17]. The effect of pH on bacteriocin stability was 
determined by adjusting the pH of purified ente-
rocin CMUL20-2 to various pHs (2 to 12) using 2 
M HCl and/or 2 M NaOH. The samples were then 
incubated at 30 °C for 4 hrs, the pH was readjus-
ted back to 7.0. For storage stability, the enterocin 
was tested under different storage temperatures 
(-20, 4 and 37°C) [18]. 
Inhibitory spectrum of the purified enterocin 
CMUL20-2
In order to determine the antimicrobial spectrum of 
enterocin CMUL20-2, Gram positive (L. monocyto-
genes and S. aureus) and Gram negative bacteria 
(Escherichia coli (E. coli), Salmonella Typhimurium 
(S. Typhimurium) were tested using the agar well 
diffusion method. While for fungal procedure, few 
conidia (without mycelium) were taken from culture 
plate and then poured in 0.9% NaCl suspension. 
After dilution, the conidia concentration was de-
termined by using a cell counter under microscope. 
Once the suspension was ready (106 conidia/ml), a 
sterile swab was immersed in suspension and then 
the excess was removed by pressing the swab at 
the edges. 
Time-kill curve assay of the purified 
enterocin CMUL20-2 against L. 
monocytogenes in BHI broth and 
pasteurized milk
The time-kill curve assay was carried out in order to 
study the bactericidal activity of purified enterocin 
CMUL20-2 against L. monocytogenes during diffe-
rent intervals time (0, 2, 4, 8, 10 and 12 h). 150 
μl of purified enterocin CMUL20-2 were added to 
15 ml of BHI broth with an initial concentration of 
3.2×104 CFU/ml of L. monocytogenes. In another 
test, an initial concentration of 2.0×104 CFU/ml of L. 
monocytogenes were added to 15 ml of pasteurized 
milk, and then 150μl of purified bacteriocin were 
added. The optical density was measured at 660nm 
at each time point. A co-culture between L. mono-
cytogenes and CMUL20-2 strain (binary system 1:1) 
without pH regulation was performed. The initial 
concentration for each bacterium was 2.0×104 CFU/
ml. This mixture was incubated aerobically at 35 °C, 
and the duration of incubation was: 0, 2, 4, 8, 10 
and 12 h. Colony counts were performed by plating 
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100 μl of serial dilution of culture on differential 
agar medium RAPID L. Mono™ Chromogenic Me-
dia (Bio-Rad, Germany) followed by incubation at 
37 °C for 24 h. CFUs on each plate were counted 
and average CFU/ml was calculated. 
Strain safety assessment 
Hemolysis test
Ten microliters of overnight liquid culture were 
added in MRS broth and incubated overnight at 
37°C. A loopful of the new liquid culture was streak 
on Columbia base agar amended with sheep blood, 
then incubated anaerobically at 37°C for 16 hours. 
A strain of Staphylococcus aureus ATCC ® 25923™ 
was used as positive control.
Antibiotic susceptibility testing
Disc diffusion method was used to screen for the 
antibiotic susceptibility of E. faecium CMUL20-2 by 
using 24 antibiotics (Bio-Rad, France). Tests were 
done according to the criteria of the National Com-
mittee of Clinical Laboratory Standards (NCCLS) 
using Müller-Hinton agar. Diameters of inhibition 
zones were measured after anaerobic incubation 
at 37ºC for 24 hrs [19]. 
Screening for the presence of virulence genes
In order to evaluate the safety of the CMUL20-2 
strain, several virulence genes have been targeted 
using conventional PCR according to [20]. The total 
DNA extraction was carried out byusing QIAamp 
DNA minikit (Qiagen, Germany) according to the 
manufacturer’s instructions. The target genes were 
gelE (gelatinase), esp (enterococcal surface of pro-
tein), asal (aggregation substance) and hyl (hyaluro-
nidase) [21]. Three clinical strains from “Collection 
Microbiologique Université Libanaise (CMUL)” were 
used as positive control for the presence of virulence 
genes.
Results 
Isolation of LAB and screening of 
enterocin activity 
A total of hundred bacterial isolates were obtained 
from twenty four samples of goat’s milk from dif-
ferent geographic sites in north of Lebanon. All of 
these bacteria shared characteristics of LAB; they 
were Gram positive, catalase negative and oxidase 
negative. All LAB were tested for their antimicrobi-
al activity against Salmonella Typhimurium ATCC® 
14028™, L. monocytogenes ATCC® 19115™, E. 
coli ATCC® 8739™ and S. aureus ATCC® 25923™ 
using agar well diffusion method as described be-
fore [22]. Only four LAB isolates (6-10, 14-1, 14-2 
and CMUL20-2) have shown an antimicrobial ac-
tivity against L. monocytogenes ATCC® 19115™. 
The CMUL20-2 isolate showed the strongest anti-
listerial activity (23 mm of diameter of inhibition 
zone).
Characterization of antimicrobial 
substances in crude supernatant
Proteinase K treated supernatant lost its anti-listerial 
activity, whereas in presence of lipase and amylase 
the activities persisted indicating the proteinous na-
ture of this substance.
Strain identification
The strain CMUL20-2 was Gram positive cocci and 
didn’t exhibit a catalase activity. Other parameters 
were evaluated such as the ability of growth at 
different temperatures. The CMUL20-2 strain was 
able to grow at 6.8% of NaCl but not at 10 and 
18% of NaCl. Moreover, this strain could grow at 
various pH values (4, 5, 6, 7, 8 and 9) but not at 
pH 2 and 3. Based on the route for identification 
of LAB, the strain CMUL20-2 was identified as En-
terococcus spp., [23]. The molecular identification 
identified the active strain as E. faeciumby using 
pyrosequencing method as described before [15]. 
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New strategy of enterocin CMUL20-2 
purificationand determination of the 
mass and charge 
After the modified method of extraction, the inhibi-
tion zone diameter increased from 22 mm recorded 
for crude enterocin CMUL20-2 to 25 mm and the 
activity units increased from 5120 AU/ml to 10240 
AU/ml.
Purification and molecular weight 
determination
The enterocin CMUL20-2 has been eluted at 25 % 
of acetonitrile concentration by RP-HPLC. As shown 
in Figure 2A, the retention time was at 4.7 min. 
The molecular weight of enterocin CMUL20-2 was 
3093.6 Da (Figure 2B). 
Figure 1:  Inhibition zone diameters resulted from 
different conditions of extracted entero-
cin CMUL20-2.
Figure 2.
A. RP-HPLC profile indicating the retention time of enterocin CMUL20-2. B. molecular weight determination of enterocin CMUL20-2 by LC-ESI/MS.
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Figure 3.
A. Enterocin CMUL20-2 stability under different temperature with time; B. Enterocin CMUL20-2 stability under autoclaving (121 °C) with time; C. Time kill curve 
of L. monocytogenes ATCC® 19115™ treated with CMUL20-2 bacteriocin in BHI broth; D. Time kill curve of L. monocytogenes ATCC® 19115™ treated with 
CMUL20-2 strain and it’s bacteriocin in pasteurized milk.
Characterization of enterocin CMUL20-2
Effect of different temperatures on purified 
enterocin CMUL20-2 stability
As shown in Figure. 3A, the effect of different tem-
perature on purified enterocin CMUL20-2 activity 
was evaluated by measuring the inhibition zones 
diameters. It has been found that the tested ente-
rocin was thermostable; it withstands high tempe-
rature up to 121°C, although a partial loss in the 
activity was observed with a continuous increase in 
the time of exposure to high temperature (Figure 
3A). Antibacterial activity of enterocin CMUL20-2 
was detected after 15 and 30 min at 121°C (auto-
clave), indicating that the bacteriocin is highly heat 
stable (Figure 3A, 3B). 
Stability of purified enterocin CMUL20-2 
during storage and at different pH 
The storage of purified enterocin produced by 
CMUL20-2 strain showed a high stability at –20 
and 4°C for at least six months. The antimicrobial 
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activity of bacteriocin expressed as inhibition zone 
diameter was 20 mm after 2 months at -20 °C; 
however, it was 18 mm after 2 months at 4 °C. 
Enterocin CMUL20-2 was stable at different pH 
values except pH 11 and 12. 
Inhibitory spectrum of the purified 
bacteriocin
The susceptibility of various microorganisms to en-
terocin CMUL20-2 were presented in Table 1. En-
terocin CMUL20-2 showed an antibacterial activ-
ity against L. monocytogenes ATCC® 19115™ and 
L. monocytogenes isolated from food (hotdog), 
Streptococcus bovis isolated from clinical sample 
and Clostridium perfringens isolated from meat 
sample. Furthermore, this enterocin showed high 
antifungal activity against Penicillium spp, however 
it didn’t show any activity against Aspergillus fla-
vus. 
Time-kill curve of L. monocytogenes 
ATCC® 19115™ treated with the purified 
enterocin CMUL20-2 in BHI broth and 
pasteurized milk 
The time course of killing activity using time kill 
curve assay was performed. The viable count re-
corded as CFU/ml for L. monocytogenes ATCC® 
19115™, was plotted against the exposure time of 
the bacterial cells to purified enterocin CMUL20-2. 
The changing in CFU/ml was compared to a positi-
ve control (untreated bacterial cells). Time-kill cur-
ve analysis for the bacterium treated with purified 
enterocin CMUL20-2 showed that the count of L. 
monocytogenes was rapidly reduced from 3.2×104 
CFU/ml to 1×10 CFU/ml after 2 hrs of incubation 
and then increased slowly to 1.2×104 CFU/ml after 
12 hrs comparing to positive control (7.60×1010 
CFU/ml). On the other hand, the OD660 nm of the 
L. monocytogenes test tubes was 0.06 after 12 hrs 
of incubation which was lower than the positive 
control (OD660nm=0.58) (Figure 3C). Time-kill cur-
ve analysis for the bacterium treated with purified 
bacteriocin in pasteurized milk showed that the 
count of viable L. monocytogenes in test tube in-
crease of 2 log, from 2.20×104 CFU/ml to 1.60×106 
CFU/ml after 12 hrs incubation. However, in the 
positive control an increase of 5 log was observed 
to rich a final concentration of 9.0×109 CFU/ml. 
The same result was obtained when a co-culture 
between L. monocytogenes and CMUL20-2 strain 
in pasteurized milk was carried out. The concentra-
tion of L. monocytogenes in co-culture was increa-
sed slowly from 2.2×104 CFU/ml to 8.7×106 CFU/
ml after 12 hrs of incubation in comparison with 
the positive control (9.0×109 CFU/ml) (Figure 3D). 
Table 1.  Inhibitory spectrum of the purified entero-
cin CMUL20-2.
Indicator 
organisms
Strain No
Purified 
enterocin 
CMUL20-2
L. monocytogenes ATCC® 19115™ ++
L. monocytogenes Food strain +++
L. innocua ATCC® 33090™ ++
Streptococcus bovis CMUL 425 +
Staphylococcus aureus ATCC® 25923™ -
Staphylococcus aureus CMUL 052 -
Enterococcus faecalis CMUL 624 -
Enterococcus faecium CMUL 613 -
Clostridium perfringens ATCC® 13124 +++
Bacillus cereus ATCC® 11778™ -
Lactobacillus 
acidophilus
CIP 7613  -
Lactobacillus brevis CIP102806  -
Escherichia coli ATCC® 8739™  -
Salmonella 
typhimurium
ATCC® 14028™  -
Pseudomonas 
aeruginosa
CMUL 297  -
Brucella spp. CMUL 031  -
Campylobacter jejuni CMUL 016  -
Penicillium spp. CMUL 127  ++
Aspergillus flavus CMUL 051  -
Candida albicans CMUL 15  -
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After 12 hrs of incubation, the CMUL20-2 strain, 
has slightly acidified the co-cultured milk (pH from 
6.5 to 5.5).
Strain safety assessment 
Hemolysis activity, resistance to antibiotics 
and detection of virulence genes
E. faecium CMUL20-2 didn’t exhibit any hemolytic 
activity. Moreover, E. faecium CMUL20-2 was sus-
ceptible to ciprofloxacin, amoxicillin, vancomycin, 
doxycycline, gentamicin, imipenem and moxifloxa-
cin and resistant to rifampin, bacitracin and opto-
chin. The PCR detection of virulence gene revealed 
that E. faecium CMUL20-2 didn’t harbor any of the 
virulence genes tested.
Discussion
The new strategy of extraction and purification 
was based on the adsorption-desorption capaci-
ty of some bacteriocinogenic strains. According 
to the study of Yang et al., 1992, the neutraliza-
tion of broth facilitate the adsorption of bacterio-
cin on the producing strain cell wall. In contrast, 
the acidic environment allows desorption of the 
adsorbed bacteriocins. A remarkable increasing 
of antimicrobial activity of enterocin CMUL20-2 
was shown after extraction of crude bacteriocin 
by classical adsorption-desorption method. In the 
present work (modified method), the pellets is-
sued from MRS broth (pH=4.5) were inoculated 
directly in neutral PBS (adjusted to 3 McFarland) 
without neutralization and then, the supernatant 
of inoculated PBS was taken without acidification 
step. As shown in Figure 1, the aforementioned 
supernatant showed 12 mm of inhibitory zone dia-
meter. These results suggested that the enterocin 
CMUL20-2 have been adsorbed on the producing 
strain (in acidic MRS broth) and then desorbed in 
the neutral PBS which is slightly different to the 
classical method. In order to determine the pos-
sibility of producer strain to secrete its enterocin 
in PBS solution, the producer strain was cultured 
in neutral PBS and incubated for 15 min and 18 
h separately. The anti-listerial activity showed that 
no significant difference of enterocin concentra-
tion between the two incubation times (11.2 mm 
and 11.5 mm respectively). Another hypothesis is 
that the enterocin didn’t desorbed from produ-
cer strain, but the producer strain cells was lysed 
in PBS. However, the supernatant of boiled PBS 
containing producer strain showed an increasing 
of inhibitory zone diameter = 22.4 mm. This in-
creasing of antilisterial activity may be related to 
the increasing of active enterocin. This can be due 
to the additional activity of pre-enterocin (intrace-
llular enterocin) which may be active as reported 
before by Ray et al., [24]. They showed that the 
pre-pediocine Ach was also active. The additional 
activity can be due also to pre-enterocin which 
has been heat cleaved and activated after boiling. 
In order to confirm the adsorption of enterocin on 
the producer strain’s cell wall, different concentra-
tions of producer strain (2, 3, 3.5 and 4 McFarland) 
were prepared in neutral PBS from colonies cultu-
red in MRS agar and not from broth. As shown 
in Figure 1, the activity of PBS supernatants varied 
from 9 to 15 mm. These results indicated that the 
activity is proportional to the cell concentration of 
producer strain. This present work suggests that 
CMUL20-2 strain strongly adsorbed the enterocin 
at acidic and neutral pH.
Enterocin desorption was not related to pH va-
lue only, but the lack of nutriment seems to be a 
main condition to desorb this enterocin which is 
different to the classical hypothesis[16]. In general, 
the producer strain which can adsorb its bacterio-
cin will release it in a stressful environment such 
as acidic environment and thus, it is an indicator 
of the presence of live microorganisms which take 
nutriments and secrete organic acid. In our case, 
the CMUL20-2 strain releases its enterocin in neu-
tral PBS. Therefore, the only explanation is that the 
producer strain was also present in stressful envi-
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ronment lacking nutriments which is also an indi-
cator of microorganism presence. Thus, the use of 
direct colonies of producer strain from MRS agar 
seems to be very effective strategy to purify the 
enterocin in only two steps: PBS-colonies followed 
by RP-HPLC.
Besides the modified strategy of extraction and 
purification, the present study also showed that en-
terocin CMUL20-2 exhibit a good activity against 
some foodborne pathogens as well as spoilage mi-
cro-organisms. In addition, this enterocin can resist 
to several stressful conditions such as high tempera-
ture, pressure and acidic environment. 
Conclusions 
This study proved that the present purified entero-
cin CMUL20-2 is very active AMP which can in-
hibit pathogenic foodborne bacteria and fungi. Be-
sides his antimicrobial activity, enterocin CMUL20-
2 showed a high stability under several industrial 
conditions such as high temperature, acidic environ-
ment and storage conditions and also in a complex 
food product like pasteurized milk. Moreover, the 
producer strain showed a safety status and thus has 
a potential for food application especially in food 
preservation. We suggest that this new discovered 
Lebanese enterocin with its producing strain can 
be used as safe biopreservative in many food pro-
cesses.
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